These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. Murphy LJ, Murphy LC, Stead B, Sutherland RL, Lazarus L. J Clin Endocrinol Metab; 1986 Feb; 62(2):280-7. PubMed ID: 3001123 [Abstract] [Full Text] [Related]
6. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D). Leroy-Martin B, Peyrat JP. Anticancer Res; 1989 Feb; 9(3):631-6. PubMed ID: 2764510 [Abstract] [Full Text] [Related]
7. Evolution of prolactin and placental lactogen receptors in ewes during pregnancy and lactation. Emane MN, Delouis C, Kelly PA, Djiane J. Endocrinology; 1986 Feb; 118(2):695-700. PubMed ID: 3002762 [Abstract] [Full Text] [Related]
8. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. Gutzman JH, Miller KK, Schuler LA. J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085 [Abstract] [Full Text] [Related]
9. Prolactin receptors in human breast cancer cells in long-term tissue culture. Shiu RP. Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585 [Abstract] [Full Text] [Related]
10. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor. Lorenson MY, Ueda EK, Chen KE, Walker AM. Am J Physiol Endocrinol Metab; 2012 Mar 01; 302(5):E585-94. PubMed ID: 22205628 [Abstract] [Full Text] [Related]
12. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE. Clin Cancer Res; 1999 Nov 01; 5(11):3583-93. PubMed ID: 10589775 [Abstract] [Full Text] [Related]
13. Characterization of prolactin receptors in human breast cancer. Peyrat JP, Djiane J, Kelly PA, Vandewalle B, Bonneterre J, Demaille A. Breast Cancer Res Treat; 1984 Nov 01; 4(4):275-81. PubMed ID: 6097324 [Abstract] [Full Text] [Related]
14. Seminal plasma factors induce in vitro PRL secretion in smooth muscle cells of the human prostate. Untergasser G, Rumpold H, Plas E, Witkowski M, Berger P. J Clin Endocrinol Metab; 2001 Nov 01; 86(11):5577-84. PubMed ID: 11701738 [Abstract] [Full Text] [Related]
15. Induction of prolactin (PRL) receptors by PRL in the rat lung and liver. Demonstration and characterization of a soluble receptor. Amit T, Barkey RJ, Gavish M, Youdim MB. Endocrinology; 1984 Feb 01; 114(2):545-52. PubMed ID: 6317358 [Abstract] [Full Text] [Related]
16. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V. Oncogene; 2000 Sep 28; 19(41):4695-705. PubMed ID: 11032019 [Abstract] [Full Text] [Related]
17. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone. Shiu RP, Paterson JA. Cancer Res; 1984 Mar 28; 44(3):1178-86. PubMed ID: 6692402 [Abstract] [Full Text] [Related]
18. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI, Sutherland RL. J Clin Endocrinol Metab; 1997 Nov 28; 82(11):3692-9. PubMed ID: 9360527 [Abstract] [Full Text] [Related]
19. Regulation of lactogenic hormone binding in rat liver by steroid hormones. Sherman BM, Stagner JI, Zamudio R. Endocrinology; 1977 Jan 28; 100(1):101-7. PubMed ID: 187403 [Abstract] [Full Text] [Related]